Showing posts with label 202008. Show all posts
Showing posts with label 202008. Show all posts

9 November 2020

NICE COVID-19 rapid guidelines

COVID-19 rapid reviews of interest to Specialised commissioning
NICE 
Check NICE website for new guidelines and updates


19 August 2020

Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps

Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps
Scottish Health Technologies Group Recommendation August 2020
  • Clinical and cost effectiveness of PillCam™ Colon-2 (second-generation colon capsule endoscopy (CCE-2)), compared with optical colonoscopy or computed tomographic colonography (CTC), for identifying colorectal polyps in adults with signs or symptoms of colorectal cancer or at increased risk of colorectal cancer.

13 August 2020

Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus

Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
Annals of Oncology 31 July 2020 DOI:https://doi.org/10.1016/j.annonc.2020.07.010
  • We established an international consortium to discuss clinical evidence and to provide expert advice on statements related to cancer management during COVID-19 pandemics. The expert panel agreed on 28 statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning.

National Lung Cancer Audit – Annual Reports

National Lung Cancer Audit annual report (for the audit period 2018)
HQIP 13 Aug 2020
  • The audit makes 13 specific recommendations around quality improvement highlighting deviation from National Institute for Health and Care Excellence (NICE) guidelines and other nationally recognised standards of care.

National Lung Cancer Audit – Annual Report 2018
HQIP 9 May 2019
  • This NLCA annual report represents the culmination of nearly 2 years of patient care and follow up, data collection, data analysis and interpretation.

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
The Lancet Oncology v21(8), P1023-1034, AUGUST 01, 2020 DOI:https://doi.org/10.1016/S1470-2045(20)30388-0
  • Estimated the impact of delays in diagnosis on cancer survival outcomes in four major tumour types.

12 August 2020

Deep brain stimulation for refractory epilepsy in adults [IPG678]

Deep brain stimulation for refractory epilepsy in adults [IPG678]
NICE Interventional procedures guidance 12 August 2020
  • The procedure should only be done in neurosurgery centres that specialise in managing epilepsy.

7 August 2020

What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis

What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis 
J Crit Care. 2020;60:183-194. doi:10.1016/j.jcrc.2020.08.003
  • A systematic review and metaanalysis for six factors from 28 papers and concluded that patients with mechanical ventilation, hypomagnesemia, delirium, and malnutrition tend to have longer ICU stay, and that age and gender were not significant factors. This work suggested a list of risk factors that should be considered in prediction models for ICU LoS, as follows: severity scores, mechanical ventilation, hypomagnesemia, delirium, malnutrition, infection, trauma, red blood cells, and PaO2:FiO2. 
Abstract


1 August 2020

Maintaining a cancer service in the midst of the COVID-19 pandemic: A single centre experience

Maintaining a cancer service in the midst of the COVID-19 pandemic: A single centre experience
NICE August 2020
  • A shared learning case study from Bristol Haematology and Oncology Centre around delivery of NICE’s rapid Covid-19 guideline "NG161: delivery of systemic anticancer treatments". 

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
The Lancet Oncology v 21(8), P1035-1044, August 01, 2020 DOI:https://doi.org/10.1016/S1470-2045(20)30392-2
  • The researchers used age-stratified and stage-stratified 10-year cancer survival estimates for patients in England, UK, for 20 common tumour types diagnosed in 2008–17 at age 30 years and older from Public Health England. We also used data for cancer diagnoses made via the 2-week-wait referral pathway in 2013–16 from the Cancer Waiting Times system from NHS Digital.

31 May 2020

Cost-effectiveness Applications of Patient-reported Outcome Measures (PROMs) in Spine Surgery.

Cost-effectiveness Applications of Patient-reported Outcome Measures (PROMs) in Spine Surgery.
Clin Spine Surg. 2020;33(4):140-145. doi:10.1097/BSD.0000000000000982
  • On the basis of the health-related quality of life outcomes, the cost-effectiveness of various spine surgeries can be determined, such as cervical fusions, lumbar fusions, microdiscectomies.

Abstract

1 August 2019

The European study on centralisation of childhood cancer treatment.

The European study on centralisation of childhood cancer treatment.
Eur J Cancer. 2019;115:120-127. doi:10.1016/j.ejca.2019.04.024
  • An examination of treatment outcomes for childhood cancer across Belgium, Bulgaria, Finland, Ireland, the Netherlands and Slovenia in high- or low-volume hospitals found that treatment centralisation is associated with survival benefits.

Abstract